Browse result page of CancerPDF Database
Please click on CancerPDF_ID for detailed information about peptide.
| CancerPDF_ID | Peptide seq | Protein Name | Fluid | Mass/Z | Profiling Technique | Cancer Type | Expression Regulation | PUBMED ID |
|---|---|---|---|---|---|---|---|---|
| CancerPDF_ID8703 | APDNLDPIPK | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8704 | APDNLDPIPKN | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8742 | DDLQDFLSKD | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8769 | DPAKLDQIES | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8822 | FAPDNLDPIPKN | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8825 | FDPAKLDQIES | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8875 | GKFDPAKLDQIES | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8932 | HFSVIDFNQN | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8955 | IEKIQPSGGTNINEA | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8958 | IILVSDGDPTVGEL | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8959 | IILVSDGDPTVGELK | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8960 | IILVSDGDPTVGELKLS | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8965 | ILDDLRAED | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8970 | ILVSDGDPTVGEL | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8971 | ILVSDGDPTVGELK | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8972 | ILVSDGDPTVGELKLS | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9029 | LIILVSDGDPTVGE | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9030 | LIILVSDGDPTVGEL | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9031 | LIILVSDGDPTVGELK | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9032 | LIILVSDGDPTVGELKLS | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9100 | NLGLLDPNS | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9101 | NLGLLDPNSVS | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9102 | NLGLLDPNSVSL | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9109 | NNLGLLDPNS | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9110 | NNLGLLDPNSVS | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9128 | NYPHTSVTDV | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9129 | NYPHTSVTDVTQ | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9130 | NYPHTSVTDVTQN | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9131 | NYPHTSVTDVTQNN | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9301 | TILDDLRAEDH | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9441 | YPHTSVTDVTQNN | Inter-alpha (Globulin) inhibitor H2 | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |